Vertical Variation Of Pqrst Signal Waveform (e.g., Amplitude Of Qrs Complex, Etc.) Detected Patents (Class 600/517)
-
Patent number: 8249715Abstract: A system includes an implantable medical device. The implantable medical device includes a control circuit and a motion sensing device. The motion sensing device is coupled to the control circuit, and the motion sensing device is configured to transmit signals to the control circuit. The control circuit is configured to identify one or more steps of a patient using the motion sensing device signal.Type: GrantFiled: October 26, 2010Date of Patent: August 21, 2012Assignee: Cardiac Pacemakers, Inc.Inventors: Jilliann G. Fricke, Lemont Baker, Donald L. Hopper, Aaron R. McCabe, James A. Esler, Chie Kawahara
-
Patent number: 8241221Abstract: Techniques are provided for detecting stroke within a patient using an implantable medical device in conjunction with an external confirmation system. In one example, a preliminary detection of stroke is performed by a subcutaneous monitor based on an analysis of features of an electrocardiogram (ECG) sensed within the patient. Exemplary ECG features indicative of possible stroke include the onset of prominent U-waves, the onset of notched T-waves, and changes in ST segment duration or QT duration or dynamic trends in these parameters. The monitor transmits a signal indicative of possible stroke to a bedside monitor or other external system, which generates a stroke questionnaire for use in confirming the stroke. Family members or other caregivers input answers to the questionnaire into the external system, which confirms or disconfirms the stroke. Emergency personnel can be automatically notified.Type: GrantFiled: February 5, 2009Date of Patent: August 14, 2012Assignee: Pacesetter, Inc.Inventor: Euljoon Park
-
Patent number: 8224430Abstract: A system for the detection of cardiac events occurring in a human patient is provided. At least two electrodes are included in the system for obtaining an electrical signal from a patient's heart. An electrical signal processor is electrically coupled to the electrodes for processing the electrical signal and a patient alarm means is further provided and electrically coupled to the electrical signal processor. The electrical signal is acquired in the form of electrogram segments, which are categorized according to heart rate, ST segment shift and type heart rhythm (normal or abnormal). Baseline electrogram segments are tracked over time.Type: GrantFiled: September 28, 2009Date of Patent: July 17, 2012Assignee: Angel Medical Systems, Inc.Inventors: David R. Fischell, Tim A. Fischell, Jonathan Harwood, Robert E. Fischell, Steven R. Johnson, Bruce Hopenfeld, Michael Sasha John
-
Patent number: 8202224Abstract: Various techniques are provided for calibrating and estimating left atrial pressure (LAP) using an implantable medical device, based on impedance, admittance or conductance parameters measured within a patient. In one example, default conversion factors are exploited for converting the measured parameters to estimates of LAP. The default conversion factors are derived from populations of patients. In another example, a correlation between individual conversion factors is exploited to allow for more efficient calibration. In yet another example, differences in thoracic fluid states are exploited during calibration. In still yet another example, a multiple stage calibration procedure is described, wherein both invasive and noninvasive calibration techniques are exploited. In a still further example, a therapy control procedure is provided, which exploits day time and night time impedance/admittance measurements.Type: GrantFiled: April 24, 2008Date of Patent: June 19, 2012Assignee: Pacesetter, Inc.Inventors: Dan E. Gutfinger, Neal L. Eigler, Dorin Panescu, James S. Whiting
-
Patent number: 8170653Abstract: A system for the detection of cardiac events occurring in a human patient is provided. At least two electrodes are included in the system for obtaining an electrical signal from a patient's heart. An electrical signal processor is electrically coupled to the electrodes for processing the electrical signal and a patient alarm means is further provided and electrically coupled to the electrical signal processor. The electrical signal is acquired in the form of electrogram segments, which are categorized according to heart rate, ST segment shift and type heart rhythm (normal or abnormal). Baseline electrogram segments are tracked over time.Type: GrantFiled: February 6, 2009Date of Patent: May 1, 2012Assignee: Angel Medical Systems, Inc.Inventors: David R. Fischell, Jonathan Harwood, Steven R. Johnson, David Keenan
-
Patent number: 8155734Abstract: This document describes, among other things, systems and methods for characterizing a tachyarrhythmia. A method comprises obtaining a current first primary characterization of the tachyarrhythmia and a current first primary confidence level of the current first primary characterization, obtaining a current second primary characterization of the tachyarrhythmia and a current second primary confidence level of the current second primary characterization, and determining a current secondary characterization using the current first primary characterization, the current first primary confidence level, the current second primary characterization, and the current second primary confidence level.Type: GrantFiled: April 19, 2006Date of Patent: April 10, 2012Assignee: Cardiac Pacemakers, Inc.Inventors: Dan Li, Benjamin Ettori
-
Publication number: 20120053479Abstract: A heart monitor is disclosed. The monitor computes ST segment deviations and stores the results in heart rate based histograms. Periodically, the monitor analyzes the histogram data to determine a normal range of ST deviation for a particular heart rate range. The monitor computes heart rate dependent ischemia detection thresholds based on the upper and lower boundaries of the normal range.Type: ApplicationFiled: August 25, 2010Publication date: March 1, 2012Applicant: ANGEL MEDICAL SYSTEMS, INC.Inventor: BRUCE HOPENFELD
-
Publication number: 20120053475Abstract: Embodiments of the present invention relate to implantable systems, and methods for use therewith, for assessing a patients' myocardial electrical stability. Implanted electrodes are used to obtain an electrogram (EGM) signal, which is used to identify periods when the patient experiences T-wave alternans. Additionally, the EGM signal is used to determine whether premature ventricular contractions (PVCs) cause phase reversals of the T-wave alternans. The patient's myocardial electrical stability is assessed based on whether, and in a specific embodiment the extent to which, PVCs cause phase reversals of the T-wave alternans. This abstract is not intended to be a complete description of, or limit the scope of, the invention.Type: ApplicationFiled: May 31, 2011Publication date: March 1, 2012Inventor: Taraneh Ghaffari Farazi
-
Patent number: 8126539Abstract: An implantable medical device and associated method assess T-wave alternans by sensing a cardiac electrogram (EGM) signal and selecting a pair of consecutive T-wave signals from the EGM signal. A first amplitude and a second amplitude from each of the consecutive T-wave signals are determined. The differences between the first amplitudes and the second amplitudes of the consecutive T-wave signal pairs are used to compute a T-wave alternans metric.Type: GrantFiled: October 12, 2007Date of Patent: February 28, 2012Assignee: Medtronic, Inc.Inventors: Xiaohong Zhou, Jeffrey M. Gillberg
-
Patent number: 8112149Abstract: A system and method determining physiological status of a patient. A determination is made whether the patient is sleeping. The amplitude and change in voltage over time of any intramyocardial electrogram is measured for a right ventricle and a left ventricle of a heart of the patient for a predefined number of heartbeats at a specified time interval in response to determining the patient is asleep. The measurements are averaged for the right ventricle and left ventricle. The averaged measurements are transmitted to a receiver for communication to an intended recipient.Type: GrantFiled: February 27, 2007Date of Patent: February 7, 2012Assignee: Monitoring Information Technologies, Inc.Inventor: Jason Sholder
-
Patent number: 8090435Abstract: Techniques are described for detecting ischemia, hypoglycemia or hyperglycemia based on intracardiac electrogram (IEGM) signals. Ischemia is detected based on a shortening of the interval between the QRS complex and the end of a T-wave (QTmax), alone or in combination with a change in ST segment elevation. Alternatively, ischemia is detected based on a change in ST segment elevation combined with minimal change in the interval between the QRS complex and the end of the T-wave (QTend). Hypoglycemia is detected based on a change in ST segment elevation along with a lengthening of either QTmax or QTend. Hyperglycemia is detected based on a change in ST segment elevation along with minimal change in QTmax and in QTend. By exploiting QTmax and QTend in combination with ST segment elevation, changes in ST segment elevation caused by hypo/hyperglycemia can be properly distinguished from changes caused by ischemia.Type: GrantFiled: January 27, 2009Date of Patent: January 3, 2012Assignee: Pacesetter, Inc.Inventors: Jong Gill, Peter Boileau, Rupinder Bharmi, Xiaoyi Min, Joseph J. Florio, Michael E. Benser, Gene A. Bornzin
-
Patent number: 8078271Abstract: Techniques are described for detecting and distinguishing among ischemia, hypoglycemia or hyperglycemia based on intracardiac electrogram (IEGM) signals. In one technique, these conditions are detected and distinguished based on an analysis of: the interval between the QRS complex and the peak of a T-wave (QTmax), the interval between the QRS complex and the end of a T-wave (QTend), alone or in combination with a change in ST segment elevation. By exploiting QTmax and QTend in combination with ST segment elevation, changes in ST segment elevation caused by hypo/hyperglycemia can be properly distinguished from changes caused by cardiac ischemia. In another technique, hyperglycemia and hypoglycemia are predicted, detected and/or distinguished from one another based on an analysis of the amplitudes of P-waves, QRS-complexes and T-waves within the IEGM. Appropriate warning signals are delivered and therapy is automatically adjusted.Type: GrantFiled: March 18, 2009Date of Patent: December 13, 2011Assignee: Pacesetter, Inc.Inventor: Rupinder Bharmi
-
Patent number: 8073536Abstract: A method and system for determining undersensing during post-processing of sensing data generated by a medical device that includes transmitting a plurality of stored sensing data generated by the medical device to an access device, the stored sensing data including sensed atrial events and sensed ventricular events. The access device determines, in response to the transmitted data, instances where the medical device identified a cardiac event being detected in response to the sensing data, and determines whether one of a predetermined number of undersensing criteria have been met in response to the transmitted data.Type: GrantFiled: November 28, 2006Date of Patent: December 6, 2011Assignee: Medtronic, Inc.Inventors: Bruce D. Gunderson, Mark L. Brown, Amisha Somabhai Patel
-
Patent number: 8050762Abstract: Methods and systems for detecting capture using pacing artifact cancellation are described. One or more pacing artifact templates are provided and a cardiac signal is sensed in a cardiac verification window. Each of the pacing artifact templates may characterize the pacing artifact associated with a particular pacing energy level, for example. A particular pacing artifact template is canceled from the cardiac signal. Capture is determined using the pacing artifact canceled cardiac signal. Detection of fusion/pseudofusion beats may be accomplished by comparing a cardiac signal to a captured response template.Type: GrantFiled: March 15, 2010Date of Patent: November 1, 2011Inventors: Jaeho Kim, Joseph Bocek
-
Patent number: 8050751Abstract: Techniques for determining whether artifacts are present in a cardiac electrogram are described. According to one example, a medical device senses a cardiac electrogram via electrodes. The medical device determines a derivative, e.g., a second order derivative, the electrogram. The medical device detects beats within the derivative, e.g., by comparing a rectified version of the derivative to one or more thresholds determined based on a maximum of the rectified derivative. The medical device determines whether the beats are periodic, and determines whether artifacts are present in the cardiac electrogram based on the determination of whether the beats are periodic. The medical device may further determine whether tachyarrhythmia is present and/or whether the cardiac rhythm of the patient is treatable based on the determination of whether the beats are periodic. For example, the medical device may determine that an electrogram is not treatable when the beats are periodic.Type: GrantFiled: July 31, 2008Date of Patent: November 1, 2011Assignee: Medtronic, Inc.Inventors: Xusheng Zhang, Raja N. Ghanem, Robert W. Stadler
-
Patent number: 8024030Abstract: A system for analyzing an ECG signal is provided. The system comprises an interface that receives an ECG waveform associated with heart beat cycle of a patient. The system includes signal processor that determines a first isoelectric portion lying between a T-wave of a first heart beat cycle and a P-wave of a successive heart beat cycle, and a second isoelectric portion lying between a P-wave and a QRS complex of the first heart beat cycle. The signal processor determines a stability measure for each of said first and second portions and adaptively selects the first or the second portion as a baseline for the first heart beat cycle based on the stability measures. The signal processor determines a point of reference on an ST segment associated with the first heart beat cycle and evaluates a deviation of the point of reference on the ST segment from the selected baseline.Type: GrantFiled: August 12, 2009Date of Patent: September 20, 2011Assignee: Siemens AktiengesellschaftInventors: Antony Louis Piriyakumar Douglas, Wiebke Schulleri
-
Patent number: 8014852Abstract: A system, method and apparatus for detecting a cardiac event in a subject, may include at least one electrode attached to the subject for obtaining an electrocardiogram of the subject's heart, and determination means for determining a size of an area under a QRS complex of the electrocardiogram. The at least one electrode may be attached to the subject's skin or to the subject's heart. Preferably, the determination means for determining the size of the area under the QRS complex of the electrocardiogram is either visual or quantitative. The subject may be a human being or an animal. The size of the area under the QRS complex of the electrocardiogram determined by the determination means is directly proportional to the mass of a viable myocardium in the subject's heart. The cardiac event that may be detected may be degenerative cardiomyopathy, acute myocardial infarction, arrhythmia, myocardial ischaemia, or compromised ventricular function.Type: GrantFiled: October 25, 2005Date of Patent: September 6, 2011Inventors: Alfred Tai Chuan Kwek, Narayan Nimbkar
-
Patent number: 8000790Abstract: An implantable cardiac stimulation device has an atrial detector that detects atrial events of a patient's heart, and a memory in which sequences of IEGM signals are stored, having a predetermined length, and an analyzing unit that analyzes the sequences to determine if the stored sequences contain atrial events having a lower amplitude than the current sensitivity setting of the atrial detector. A control unit is connected to the atrial detector to adjust the sensitivity setting thereof to a threshold that is determined based on the aforementioned analysis of the IEGM signals.Type: GrantFiled: October 27, 2003Date of Patent: August 16, 2011Assignee: St. Jude Medical ABInventors: Anders Björling, Nils Holmström, Karin Järverud, Martin Obel
-
Patent number: 7991458Abstract: The present invention relates to a system or method for analyzing drug influence on ECG curvature and Long QT Syndrome. The system has an input means connected to an ECG source, where different parameters of a received ECG curvature are indicated and/or isolated for indicating possible symptoms which relate to certain diseases that influence the ECG curvature. The aim of the invention is to achieve a system and a method for diagnosing Long QT Syndrome in an objective, fast and effect way by indication of a number of symptoms derivable from an ECG curve. Further aim is to achieve an effective test of drug influence on ECG curvature. The system analyzes the QT curvature of the ECG curvature for indicating Long QT Syndrome.Type: GrantFiled: October 20, 2004Date of Patent: August 2, 2011Assignee: Aalborg UniversitetInventors: Thomas Bork Hardahl, Claus Graff, Mads Peter Andersen, Egon Toft, Johannes Jan Struijk, Joergen Kim Kanters
-
Patent number: 7991456Abstract: Systems and methods are provided for monitoring a cardiac condition of a patient. The system includes a sensor for receiving a patient's heart rate and a processor that is programmable to set a patient's safe heart rate zone. The processor is also configured to determine whether the patient's heart rate has exceeded the safe heart rate zone. In response to determining that the patient's heart rate has exceeded the safe heart rate zone, the processor may reprogram a new safe heart rate zone.Type: GrantFiled: August 18, 2008Date of Patent: August 2, 2011Assignee: Medtronic, Inc.Inventor: Theodore Chow
-
Patent number: 7979123Abstract: A device and method for delivering electrical stimulation to the heart in a manner which provides a protective effect against subsequent ischemia is disclosed. The protective effect is produced by configuring a cardiac pacing device to intermittently switch from a normal operating mode to a stress augmentation mode in which the spatial pattern of depolarization is varied to thereby subject a particular region or regions of the ventricular myocardium to increased mechanical stress.Type: GrantFiled: October 8, 2007Date of Patent: July 12, 2011Assignee: Cardiac Pacemakers, Inc.Inventors: Frits Prinzen, Richard Cornelussen, Ward Vanagt, Joseph M. Pastore, Julio C. Spinelli
-
Patent number: 7970473Abstract: Methods and systems are provided for performing ventricular arrhythmia monitoring using at least two sensing channels that are each associated with different sensing vectors, for example by different pairs of extracardiac remote sensing electrodes. Myopotential associated with each of the sensing channels in monitored, and a ventricular arrhythmia monitoring mode is selected based thereon (e.g., based on determined myopotential levels). Ventricular arrhythmia monitoring is then performed using the selected monitoring mode.Type: GrantFiled: October 2, 2008Date of Patent: June 28, 2011Assignee: Pacesetter, Inc.Inventors: Yelena Nabutovsky, Taraneh Ghaffari Farazi, Anders Bjorling, Kjell Noren, Gene A. Bornzin
-
Patent number: 7925336Abstract: A method of discriminating between ischemic and cardiac memory effects in a heart, comprising receiving electrocardiographic (ECG) data, calculating, from the ECG data, a direction of a T-wave vector, diagnosing ischemia if the T-wave vector is between about 75 degrees and about 200 degrees, and diagnosing cardiac memory if the T-wave vector is between about zero degrees and minus 90 degrees. Also presented is a system for discriminating between ischemic and cardiac memory effects in a heart comprising means for performing an electrocardiogram, means for calculating a direction of a T-wave vector, means for diagnosing ischemia if the T-wave vector is between about 90 degrees and 180 degrees, and means for diagnosing cardiac memory if the T-wave vector is between about zero degrees and minus 90 degrees.Type: GrantFiled: October 2, 2009Date of Patent: April 12, 2011Assignee: Beth Israel Deaconess Medical CenterInventors: Alexei V. Shvilkin, Mark E. Josephson
-
Patent number: 7920912Abstract: A system and method for triggering an external device in response to an electrocardiogram signal. In one embodiment the method includes determining a peak in the electrocardiogram signal, determining if the electrocardiogram signal is rising or falling at the peak in the signal and triggering a device in response to the rising or falling peak. In one embodiment of the invention an external trigger signal is produced only a rising peak is detected. In one embodiment, the system includes a microprocessor, a peak detector and a trigger circuit. The trigger circuit outputs a trigger signal to an external device when signaled by the peak detector and not inhibited by a signal from the microprocessor.Type: GrantFiled: December 15, 2005Date of Patent: April 5, 2011Assignee: Ivy Biomedical Systems, Inc.Inventors: Mark Steven Harris, Richard Alan Mentelos
-
Patent number: 7894889Abstract: A method comprising sensing at least one cardiac signal representative of cardiac activity of a subject using an implantable medical device (IMD), calculating, from the cardiac signal, a first dominant vector corresponding to a direction and magnitude of maximum signal power of an ST-T first segment of a cardiac cycle and a second dominant vector corresponding to a direction and magnitude of maximum signal power of a P-QRS second segment of a cardiac cycle, measuring a change in the first dominant vector, measuring a change in the second dominant vector, and subtracting the change in the second dominant vector from the measured change in the first dominant vector to form a difference.Type: GrantFiled: June 12, 2009Date of Patent: February 22, 2011Assignee: Cardiac Pacemakers, Inc.Inventor: Yi Zhang
-
Patent number: 7890161Abstract: A method for detecting the myocardial state of a heart with a measuring apparatus which includes inserting a bipolar cardiological measuring electrode (4) into a heart division (8) at an acute attachment angle (9) on the myocardium (6) of less than 90°, measuring a cardiological stimulation signal such as an IEGM in sequential cardiac cycles, and in addition, determining the positive and negative maximum amplitudes Vp and Vn of the IEGM, ascertaining an asymmetry factor ? of the stimulation signal (IEGM) of sequential cardiac cycles according to the equation ?=(Vp?|Vn|)/(Vp+|Vn|) and storing the asymmetry factor ? of sequential cardiac cycles for analysis.Type: GrantFiled: November 1, 2007Date of Patent: February 15, 2011Assignee: Biotronik CRM Patent AGInventors: Oleg Anosov, Ildar Khassanov
-
Patent number: 7869864Abstract: Disclosed herein methods, devices, and systems for detecting and diagnosing a heart disease or disorder in a subject from a prime electrocardiogram which comprises calculating at least one distribution function of the prime electrocardiogram and determining whether the distribution function is indicative of the presence of absence of the heart disease or disorder.Type: GrantFiled: July 9, 2007Date of Patent: January 11, 2011Assignee: Dynacardia, Inc.Inventors: Chi-jen Tseng, Wei-min Brian Chiu
-
Patent number: 7860559Abstract: Disclosed is a system for the detection of cardiac events that includes an implanted device called a cardiosaver, a physician's programmer and an external alarm system. The system is designed to provide early detection of cardiac events such as acute myocardial infarction or exercise induced myocardial ischemia caused by an increased heart rate or exertion. The system can also alert the patient with a less urgent alarm if a heart arrhythmia is detected. Using different algorithms, the cardiosaver can detect a change in the patient's electrogram that is indicative of a cardiac event within five minutes after it occurs and then automatically warn the patient that the event is occurring. To provide this warning, the system includes an internal alarm sub-system (internal alarm means) within the cardiosaver and/or an external alarm system (external alarm means) which are activated after the ST segment of the electrogram exceeds a preset threshold.Type: GrantFiled: June 22, 2007Date of Patent: December 28, 2010Assignee: Angel Medical Systems, Inc.Inventors: David R. Fischell, Tim A. Fischell, Jonathan Harwood, Robert E. Fischell, Steven R. Johnson
-
Patent number: 7853317Abstract: A method and system decomposes a cardiac signal, such as an electrocardiogram (ECG) signal, into components. The components are then usable to assist in the detection of an abnormal heart condition. More particularly, a single lead sensor is used to generate a single lead cardiac signal. The cardiac signal is segmented into a set of cycle segments according to detected heart waveforms. The cycle segments are aligned and used to generate a set of cross-sectional signals. The cross-sectional signals are aligned and presented as inputs to a signal separation process, which separates the cardiac signal into a set of components. The components may be grouped according to predefined criteria. The components or groups may be analyzed or displayed to assist in the detection of an abnormal cardiac signal, which may be indicative of an abnormal heart condition. In one example, the signal separation process is a non-orthogonal transformation method such as independent component analysis (ICA).Type: GrantFiled: October 13, 2005Date of Patent: December 14, 2010Assignee: Sigmed, Inc.Inventors: Jeng-Ren Duann, Tzyy-Ping Jung
-
Patent number: 7844323Abstract: Disclosed is a system for the detection of cardiac events that includes an implanted device called a cardiosaver, a physician's programmer and an external alarm system. The system is designed to provide early detection of cardiac events such as acute myocardial infarction or exercise induced myocardial ischemia caused by an increased heart rate or exertion. The system can also alert the patient with a less urgent alarm if a heart arrhythmia is detected. Using different algorithms, the cardiosaver can detect a change in the patient's electrogram that is indicative of a cardiac event within five minutes after it occurs and then automatically warn the patient that the event is occurring. To provide this warning, the system includes an internal alarm sub-system (internal alarm means) within the cardiosaver and/or an external alarm system (external alarm means) which are activated after the ST segment of the electrogram exceeds a preset threshold.Type: GrantFiled: June 22, 2007Date of Patent: November 30, 2010Assignee: Angel Medical Systems, Inc.Inventors: David R. Fischell, Tim A. Fischell, Jonathan Harwood, Robert E. Fischell, Steven R. Johnson
-
Patent number: 7844336Abstract: This document discusses, among other things, a system including an implantable medical device. The implantable medical device includes a control circuit and a motion sensing device. The motion sensing device is coupled to the control circuit, and the motion sensing device is configured to transmit signals to the control circuit. The control circuit is configured to identify one or more steps of a patient using the motion sensing device signal.Type: GrantFiled: April 10, 2007Date of Patent: November 30, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: Jilliann G. Fricke, Lemont Baker, Donald L. Hopper, Aaron McCabe, James A. Esler, Chie Kawahara
-
Publication number: 20100280394Abstract: In a device and a method for providing correlated measures for predicting potential occurrence of atrial fibrillation, an impedance of the patient is measured to obtain impedance information; cardiogenic data is determined from the information; respiratory data is determined from the information; at least one hemodynamic measure is calculated from the cardiogenic data and at least one apnea measure is calculated from the respiratory data; the hemodynamic and apnea measures are correlated such that the correlated measures can be utilized for predicting potential occurrence of atrial fibrillation.Type: ApplicationFiled: January 28, 2008Publication date: November 4, 2010Inventor: Andreas Blomqvist
-
Patent number: 7826893Abstract: An implantable medical device and associated method for automatically generating morphology templates during fast cardiac rhythms, confirming a provisional template as a confirmed template, and using the confirmed template to classify subsequent detected arrhythmias. A provisional SVT template may be created during a fast ventricular rate and activated as a confirmed SVT template upon verification that the fast rate was due to an SVT. The confirmed SVT template may be used to discriminate SVT from VT/VF.Type: GrantFiled: June 4, 2007Date of Patent: November 2, 2010Assignee: Medtronic, Inc.Inventors: Jian Cao, Jeffrey M. Gillberg, Chris J. Gennaro
-
Patent number: 7801594Abstract: A morphology discrimination scheme extracts shape characteristics from cardiac signals and identifies an associated cardiac condition based on the shape characteristics. For example, internal data structures may be updated to match the shape characteristics of a known condition (e.g., a patient's normal sinus rhythm). Similarly acquired shape characteristics obtained in conjunction with a later event (e.g., QRS complexes acquired during a tachycardia episode) may be compared with the previously stored shape characteristics to characterize the later event. In some aspects the shape characteristics relate to inflection points of cardiac signals.Type: GrantFiled: October 22, 2007Date of Patent: September 21, 2010Assignee: Pacesetter, Inc.Inventor: Paul Higham
-
Patent number: 7792571Abstract: Estimating a frequency of a sampled cardiac rhythm signal and classifying the rhythm. The received signal is sampled and transformed into a curvature series. A lobe in the curvature series corresponds to a characteristic point in the sampled series. Characteristic points are selected based on a time of a lobe in the curvature series and, in one embodiment, an amplitude of the signal at the time of the lobe. A frequency of the sampled series is estimated by autocorrelating a function of the series of the characteristic points. In one embodiment, the function is a time difference function. The rhythm is classified by plotting the timewise proximity of characteristic points derived from an atrial signal with characteristic points derived from a ventricular signal. Regions of the plot are associated with a particular rhythm and the grouping of the data corresponds to the classification.Type: GrantFiled: June 27, 2003Date of Patent: September 7, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: Robert J. Sweeney, Carlos Ricci
-
Patent number: 7769437Abstract: A method for operating a cardiac rhythm management device in which a clinical state vector is computed as a combination of a plurality of parameters related to a patient's heart failure status and compared to a previously computed clinical state vector to determine a clinical trajectory indicative of changes in the patient's heart failure status. Such detected changes in status can be used both as a clinical tool to evaluate treatment and to automatically adjust the operation of the device.Type: GrantFiled: December 12, 2005Date of Patent: August 3, 2010Assignee: Cardiac Pacemakers, Inc.Inventors: Qingsheng Zhu, Julio C. Spinelli, Bruce H. KenKnight, Jay A. Warren
-
Patent number: 7769436Abstract: Techniques are described for adaptively adjusting detection thresholds for use in detecting cardiac ischemia and other abnormal physiological conditions based on morphological parameters derived from intracardiac electrogram (IEGM) signals, impedance measurements, or other signals. In one example, where ST segment elevation is used to detect cardiac ischemia, default detection thresholds are determined in advance from an examination of variations in ST segment elevations occurring within a population of patients. Thereafter, an individual pacemaker or other implantable medical device uses the default thresholds during an initial learning period to detect ischemia within the patient in which the device is implanted. During the initial learning period, the pacemaker also collects data representative of the range of variation in ST segment elevations occurring within the patient.Type: GrantFiled: June 4, 2007Date of Patent: August 3, 2010Assignee: Pacesetter, Inc.Inventors: Peter Boileau, Jay Snell, Rupinder Bharmi, Laleh Jalali, Gene A. Bornzin
-
Patent number: 7761150Abstract: A method of detecting a cardiac event in a medical device that includes determining a first characteristic in response to cardiac signals sensed along a first sensing vector over a predetermined sensing window and in response to cardiac signals sensed along a second sensing vector over the predetermined sensing window, determining a second characteristic in response to cardiac signals sensed along the first sensing vector over the predetermined sensing window and in response to cardiac signals sensed along the second sensing vector over the predetermined sensing window, and determining a third characteristic in response to cardiac signals sensed along the first sensing vector over the predetermined sensing window and in response to cardiac signals sensed along the second sensing vector over the predetermined sensing window.Type: GrantFiled: April 28, 2006Date of Patent: July 20, 2010Assignee: Medtronic, Inc.Inventors: Raja N. Ghanem, Robert W. Stadler, Xusheng Zhang
-
Patent number: 7761142Abstract: A method of detecting a cardiac event in a medical device that includes sensing cardiac signals from a plurality of electrodes forming a first sensing vector and a second sensing vector, determining inflections of the sensed cardiac signals, generating a pulse amplitude threshold in response to the determined inflections, and determining whether the inflections are indicative of noise in response to the determined inflections and the generated pulse amplitude threshold.Type: GrantFiled: April 28, 2006Date of Patent: July 20, 2010Assignee: Medtronic, Inc.Inventors: Raja N. Ghanem, Robert W. Stadler, Xusheng Zhang
-
Patent number: 7756572Abstract: Techniques are described for efficiently detecting and distinguishing among cardiac ischemia, hypoglycemia or hyperglycemia based on intracardiac electrogram (IEGM) signals. In one example, a preliminary indication of an episode of cardiac ischemia is detected based on shifts in ST segment elevation within the IEGM. In response, the implanted device then records additional IEGM data for transmission to an external system. The external system analyzes the additional IEGM data to confirm the detection of cardiac ischemia using a more sophisticated analysis procedure exploiting additional detection parameters. In particular, the external system uses detection parameters capable of distinguishing hypoglycemia, hyperglycemia and hyperkalemia from cardiac ischemia, such as QTmax and QTend intervals. Alternatively, the more sophisticated analysis procedure may be performed by the device itself, if it is so equipped. Other examples described herein pertain instead to the detection of atrial fibrillation.Type: GrantFiled: April 25, 2007Date of Patent: July 13, 2010Assignee: Pacesetter, Inc.Inventors: Mohssen Fard, Xiaoyi Min, Peter Boileau, Jong Gill, Bing Zhu, Jay Snell, Laleh Jalali, Josh Reiss, Gene Bornzin
-
Patent number: 7756570Abstract: An exemplary method to reduce risk of ventricular oversensing includes sensing, in vivo, amplitude of electrical cardiac activity, comparing sensed amplitude to a low sensitivity threshold where if the comparing indicates that sensed amplitude does not meet or exceed the low sensitivity threshold then further comparing the sensed amplitude to a high sensitivity threshold and if the further comparing indicates that sensed amplitude meets or exceeds the high sensitivity threshold then determining that ventricular fibrillation may exist. Various exemplary devices, systems, methods, etc., are disclosed.Type: GrantFiled: May 1, 2006Date of Patent: July 13, 2010Assignee: Pacesetter, Inc.Inventor: Gene A. Bornzin
-
Patent number: 7756571Abstract: Embodiments of the present invention relate to implantable systems, and method for use therein, that can detect T-wave alternans. In accordance with specific embodiments of the present invention, intrinsic premature contractions of the ventricles are detected, and at least one metric of T-waves is measured in a specified number of beats that follow each detected intrinsic premature contraction of the ventricles. A determination of whether T-wave alternans are present is made based on the measured T-wave metrics. In alternative embodiments, rather than waiting for intrinsic premature contractions of the ventricles, premature contractions of the ventricles are caused on demand by inducing premature atrial contractions. In still other embodiments, a patient's vagus nerve is stimulated to simulate premature contractions of the ventricles. This abstract is not intended to be a complete description of, or limit the scope of, the invention.Type: GrantFiled: September 16, 2005Date of Patent: July 13, 2010Assignee: Pacesetter, Inc.Inventor: Taraneh Ghaffari Farazi
-
Patent number: 7751876Abstract: A system and method for automatically detecting abnormal heart contractions originating in the ventricles, in a way that is independent of signal morphology is provided. As an uninterrupted series of ventricular detections indicates a possible ventricular arrhythmia, all ventricular beats are detected including isolated premature ventricular contractions (PVCs) and the associated R-R intervals are corrected. Premature ventricular contractions (ectopic beats) in non-standard lead configuration in a noisy signal from an ambulatory subject from a low-cost sensor that may be a small form factor sensor with 1 inch lead separation and may be rotated through multiple placements to correct an R-R interval time series used to detect atrial fibrillation.Type: GrantFiled: September 23, 2005Date of Patent: July 6, 2010Assignee: Hewlett-Packard Development Company, L.P.Inventor: Jennifer Healey
-
Publication number: 20100145206Abstract: One or more electrocardiographic signals are detected from a subject. The occurrence of alternans in the electrocardiographic signals are detected using one or more processors. One or more characteristics of detected alternans are determined. The determined characteristics of the detected alternans are analyzed to determine whether cardiac ischemia is present.Type: ApplicationFiled: December 3, 2009Publication date: June 10, 2010Applicant: Cambridge Heart, Inc.Inventors: Lahn Fendelander, Ali Haghighi-Mood, Richard J. Cohen
-
Patent number: 7734336Abstract: A method of detecting a cardiac event in a medical device that includes sensing cardiac signals from a plurality of electrodes forming a first sensing vector and a second sensing vector, determining inflections of the sensed cardiac signals, generating a pulse amplitude threshold in response to the determined inflections, determining whether the sensed cardiac signals are corrupted by noise in response to the determined inflections and the generated pulse amplitude threshold, and determining, in response to the sensed cardiac signals being corrupted by noise, whether the sensed cardiac signals are both corrupted by noise and shockable.Type: GrantFiled: April 28, 2006Date of Patent: June 8, 2010Assignee: Medtronic, Inc.Inventors: Raja N. Ghanem, Robert W. Stadler, Xusheng Zhang
-
Publication number: 20100106035Abstract: A method of classifying arrhythmias using scatter plot analysis to define a measure of variability of a cardiac rhythm parameter such as for example, without limitation, R-R interval, A-A interval, and the slope of a portion of a cardiac signal, is disclosed. The variability measurement is derived from a scatter plot of a cardiac rhythm parameter, employing a region counting technique that quantifies the variability of the cardiac rhythm parameter while minimizing the computational complexity. The method may be employed by an implantable medical device or system, such as an implantable pacemaker or cardioverter defibrillator, or by an external device or system, such as a programmer or computer. The variability measurement may be correlated with other device or system information to differentiate between atrial flutter and atrial fibrillation, for example. The variability information may also be used by the device or system to select an appropriate therapy for a patient.Type: ApplicationFiled: December 31, 2009Publication date: April 29, 2010Applicant: Medtronic, Inc.Inventors: Peter M. Van Dam, Joanneke G. Groen
-
Patent number: 7643872Abstract: A technique is provided for detecting episodes of cardiac ischemia based on an examination of the total energy of T-waves. Since cardiac ischemia is often a precursor to acute myocardial infarction (AMI) or ventricular fibrillation (VF), the technique thereby provides a method for predicting the possible onset of AMI or VF. Briefly, the technique integrates internal electrical cardiac signals occurring during T-waves and then compares the result against a running average. If the result exceeds the average by some predetermined amount, ischemia is thereby detected and a warning signal is provided to the patient. The maximum slope of the T-wave is also exploited. Techniques are also set forth herein for reliably detecting T-waves, which help prevent P-waves from being misinterpreted as T-waves on unipolar sensing channels. The T-wave detection technique may be used in conjunction with ischemia detection or for other purposes.Type: GrantFiled: March 15, 2007Date of Patent: January 5, 2010Assignee: Pacesetter, Inc.Inventors: Xiaoyi Min, Yougandh Chitre, Jeffery D. Snell, Gene A. Bornzin, Jong Kil
-
Publication number: 20090292216Abstract: In a biometric sensor provided for use with an exercise apparatus and having a pair electrodes for sensing a biopotential signal, a common-mode rejection circuit can be used to cancel noise in the signal resulting from various sources including motion of the apparatus.Type: ApplicationFiled: May 20, 2008Publication date: November 26, 2009Inventors: Russell W. Krch, SR., Emil S. Golen, Gregory A. Joseph
-
Patent number: 7623913Abstract: Methods for performing cardiac signal analysis in an implanted medical device, and devices configured to perform illustrative methods of cardiac signal analysis. A cardiac signal is captured by an implanted device using implanted electrodes and, during at least certain conditions, the cardiac signal undergoes heuristic filtering. In some embodiments, heuristic filtering is achieved by modifying a signal or value that is used as an indicator of received signal amplitude. In an illustrative example, the heuristic filtering includes periodically incrementing or decrementing the signal or value toward a desired quiescent point, where the heuristic filter period is significantly longer than the sampling period for the signal itself. In another illustrative example, the heuristic filter frequency can be adjusted dynamically to keep the signal average near the desired quiescent point.Type: GrantFiled: August 1, 2006Date of Patent: November 24, 2009Assignee: Cameron Health, Inc.Inventor: James William Phillips
-
Patent number: RE43569Abstract: A method of determining an ischemic event includes the steps of: monitoring and storing an initial electrocardiogram vector signal (x, y, z) of a known non-ischemic condition over the QRS, ST and T wave intervals; calculating and storing a J-point of the vector signal and a maximum magnitude of a signal level over the T wave interval; monitoring a subsequent electrocardiogram vector signal over the QRS, ST and T wave intervals; measuring and storing the magnitude (Mag.) of the vector difference between a subsequent vector signal and the initial vector signal; measuring and storing the angle (Ang.Type: GrantFiled: April 26, 2007Date of Patent: August 7, 2012Assignee: ECG-Tech Corp.Inventor: Charles W. Olson